Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders

SALT LAKE CITY, July 22 /PRNewswire/ -- Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, and the University of Utah today announced that they have entered into a collaboration that allows Axial access to the University's rich genetic resources including the Utah Population Database (UPDB). UPDB is a genealogical and family history database composed of more than 6 million records that provides a rich source of information for genetic, epidemiological, demographic and public health studies which can be used to identify familial clusters of disease including spinal disorders. The UPDB combined with Axial's proprietary GenDB Genealogical Database will help Axial researchers expand the indications and patient population for the ScoliScore(TM) AIS Prognostic Test - the first test to determine the risk of progressive scoliosis - as well as expand the development of additional personalized tests for scoliosis, degenerative disc disease and other spine disorders.
MORE ON THIS TOPIC